Product NDC: | 16571-071 |
Proprietary Name: | Cefaclor |
Non Proprietary Name: | Cefaclor |
Active Ingredient(s): | 250 mg/5mL & nbsp; Cefaclor |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16571-071 |
Labeler Name: | Pack Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065412 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121031 |
Package NDC: | 16571-071-12 |
Package Description: | 150 mL in 1 BOTTLE (16571-071-12) |
NDC Code | 16571-071-12 |
Proprietary Name | Cefaclor |
Package Description | 150 mL in 1 BOTTLE (16571-071-12) |
Product NDC | 16571-071 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefaclor |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20121031 |
Marketing Category Name | ANDA |
Labeler Name | Pack Pharmaceuticals, LLC |
Substance Name | CEFACLOR |
Strength Number | 250 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |